Apparatus, system and method for coated coils
The embolic coil with a frangible or plasticizing coating addresses delivery and deployment challenges by maintaining stiffness for catheter advancement and flexibility for treatment, enhancing pushability and flexibility for precise placement.
Patent Information
- Application Number
- JP2023530196
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-11-19
- Filing Date
- 2021-11-18
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2041-11-18
AI Technical Summary
The preparation, delivery, and deployment of embolic coils in medical applications are challenging due to issues such as flexibility, fragility, and complications during catheter insertion, which can lead to prolapse, buckling, or fracture, and the need for coatings that enhance pushability while avoiding undesirable stiffness during deployment.
The use of a coating around the embolic coil that is configured to fracture or plasticize upon ejection from the catheter, transitioning from a aligned to misaligned state, using hydrophilic or hydrophobic polymers with specific molecular weights, allowing the coil to maintain stiffness for delivery and flexibility for deployment, and potentially incorporating therapeutic properties.
The coating enhances the pushability of the coil through the catheter, reduces complications during deployment, and allows the coil to adapt its properties for effective treatment by fracturing or dissolving, ensuring precise placement and therapeutic efficacy.
Smart Images

Figure 0007587040000001 
Figure 0007587040000002 
Figure 0007587040000003
Abstract
Description
[Technical field]
[0001] The present disclosure relates generally to devices, systems, and methods for coil embolization, and more particularly to applications and methods of forming coated coils. Coils, such as the embolic coils described herein, can have material properties that can aid in stiffness, flexibility, thrombogenicity, antithrombogenicity, lubricity, friction, therapy, fixation, and the like. [Background technology]
[0002] Therapeutic vascular occlusion (embolization) may be used to prevent or treat pathological conditions in situ. Embolic coils may be used to occlude blood vessels in a variety of medical applications. Preparation, delivery, and deployment (e.g., into, through, and out of catheters) of embolic coils can be difficult depending on the size, shape, flexibility, fragility, etc. of the coil and / or associated delivery device. The present disclosure may be useful with regard to these and other considerations. Summary of the Invention
[0003] In one aspect of the disclosure, the embolization system may include a microcatheter with a proximal end, a distal end, a longitudinal axis, and a working lumen therethrough. The system may include a sheath. The sheath has a proximal end, a distal end, and a delivery lumen therethrough. The distal end of the sheath may be configured to be insertable into the working lumen at the proximal end of the microcatheter. The system may include a coil having a proximal end, a distal end, and a length therebetween, the coil being slidably disposed within the sheath. A coating may be disposed about the coil. A delivery filament may be configured to be slidably disposed within the sheath proximal to the coil to release the coil from the distal end of the sheath into the working lumen of the microcatheter. The delivery filament may be configured to be slidably disposed within the working lumen of the microcatheter proximal to the coil to release the coil from the working lumen at the distal end of the microcatheter to the target site. The coating may be configured to substantially fracture when the coil is released from the microcatheter and transitions from being substantially aligned with the longitudinal axis of the microcatheter to being substantially out of alignment with the longitudinal axis of the microcatheter, or the coating may be configured to plasticize after being released from the distal end of the sheath into an aqueous environment.
[0004] In various embodiments described herein or otherwise within the scope of the present disclosure, the coil may have a primary shape that is substantially linear when placed within the microcatheter and a secondary shape that is substantially curved linear when released from the microcatheter to the target site. The coating may be configured to substantially fracture and peel off from the coil when the coil transitions from the primary shape to the secondary shape. The coating may be formed from a hydrophilic polymer having a number average molecular weight of about 10,000 g / mol to about 1,000,000 g / mol. The coating may be disposed about an exterior surface of the coil. The coil may include a polymer, and the coating may include at least one of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide, polyvinyl alcohol, polyacrylic acid, polyacrylamide, hydroxypropyl methacrylamide, and polyamine. The coating may include a hydrophilic polymer, and the coating is configured to substantially fracture upon release from the microcatheter. The coil may include a polymer, and the coating may include at least one of xanthan gum, pectin, chitosan, sodium alginate, sodium carboxymethylcellulose, hydroxypropylcellulose, hyaluronic acid, dextran, carrageenan, guar gum, cellulose ether, albumin, starch, polylactic acid homopolymer, polyglycolic acid homopolymer, copolymer of lactic acid, copolymer of glycolic acid (PLGA), polycaprolactone, polyhydroxybutyric acid, polyhydroxyalkanoate, and aliphatic polyester. The coating may include a hydrophobic polymer, and the coating is configured to plasticize after being released from the distal end of the sheath into the aqueous environment. The coil may include a prothrombotic factor covered by the coating. The delivery filament may include a distal end reversibly attached to the proximal end of the coil. At least one fiber may be attached to the coil and disposed within the coating.
[0005] In one aspect of the disclosure, an embolic coil can include a coil filament disposed in adjacent windings about a longitudinal axis. A coating can be disposed about the windings. The coating can be a frangible coating that can be configured to fracture away from the windings of a portion of the coil when the portion of the coil transitions from being substantially aligned with the longitudinal axis of the remainder of the coil, or the coating can be configured to plasticize after being released into an aqueous environment.
[0006] In various embodiments described herein or otherwise within the scope of the present disclosure, the coating may include at least one of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide, polyvinyl alcohol, polyacrylic acid, polyacrylamide, hydroxypropyl methacrylamide, and polyamine. The coating may include a hydrophilic polymer, and the coating is a frangible coating configured to fracture when a portion of the coil transitions from being substantially aligned with the longitudinal axis of the remainder of the coil. The frangible coating may include at least one of xanthan gum, pectin, chitosan, sodium alginate, sodium carboxymethylcellulose, hydroxypropylcellulose, hyaluronic acid, dextran, carrageenan, guar gum, cellulose ether, albumin, starch, polylactic acid homopolymer, polyglycolic acid homopolymer, copolymer of lactic acid, copolymer of glycolic acid (PLGA), polycaprolactone, polyhydroxybutyric acid, polyhydroxyalkanoate, and aliphatic polyester. The coating may include a hydrophobic polymer, and the coating is configured to plasticize after being released into an aqueous environment. The coil filament may have a primary shape that is substantially linear and a secondary shape that is substantially curved linear. The coating may be configured to substantially fracture away from the coil filament when the coil filament transitions from the primary shape to the secondary shape. The coating may be substantially insoluble while disposed about the winding. The coating may be substantially soluble once fractured away from the winding. The coating may have a lower coefficient of friction than the coil filament. The sheath may include a proximal end, a distal end, and a delivery lumen through the sheath. The coil may be slidably disposed within the sheath. The frangible coating may include a hydrophilic polymer having a number average molecular weight of about 10,000 g / mol to about 1,000,000 g / mol.
[0007] In one aspect of the disclosure, a method of forming a coil can include winding a coil filament into adjacent windings about a longitudinal axis. The coil filament can be immersed in a vessel holding a fluid including a hydrophilic polymer having a number average molecular weight of about 10,000 g / mol to about 1,000,000 g / mol. An end of the coil filament can be raised out of the vessel until an opposite end of the coil filament rises out of the fluid.
[0008] In various embodiments described herein or otherwise within the scope of the present disclosure, lifting the end of the coil filament may further include holding the end of the coil filament such that the end of the coil filament is substantially aligned with the longitudinal axis and each of the opposing ends of the coil filament. The adjacent windings of the coil filament may be heat set into a secondary shape. The fluid may include at least one of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide, polyvinyl alcohol, polyacrylic acid, polyacrylamide, hydroxypropyl methacrylamide, and polyamine. The fluid may include a hydrophilic polymer, and the coating is configured to be released from the microcatheter to substantially fracture. The fluid may include at least one of xanthan gum, pectin, chitosan, sodium alginate, sodium carboxymethylcellulose, hydroxypropyl cellulose, hyaluronic acid, dextran, carrageenan, guar gum, cellulose ether, albumin, and starch. The fluid may include a hydrophobic polymer, and the coating is configured to plasticize after being released from the distal end of the sheath into an aqueous environment.
[0009] Non-limiting embodiments of the present disclosure are described by way of example with reference to the accompanying drawings, which are schematic and are not intended to be drawn to scale. In the drawings, each identical or nearly identical component shown is typically represented by a single numeral. For clarity, not every component is labeled in every drawing, nor every component of each embodiment is shown unless illustration is necessary to enable a person skilled in the art to understand the present disclosure. The drawings are as follows: [Brief description of the drawings]
[0010] [Figure 1] 1A and 1B illustrate schematic diagrams of an embolic coil being deployed, according to one embodiment of the present disclosure. [Figure 2A] 1A and 1B illustrate schematic diagrams of an embolic coil immersed in a fluid, according to one embodiment of the present disclosure. [Figure 2B] 2B illustrates the embolic coil of FIG. 2A being removed from the fluid. [Figure 3A] 1A-1C are schematic diagrams illustrating the preparation of an embolic system including a sheath containing an embolic coil that has been introduced into a microcatheter, according to one embodiment of the present disclosure; [Figure 3B] 3B illustrates a schematic diagram of a delivery filament within a sheath of the embolic system of FIG. 3A, according to one embodiment of the present disclosure. [Figure 3C] 3B illustrates a schematic diagram of a coil of the embolic system of FIG. 3A being delivered at a first time point, according to an embodiment of the present disclosure. [Figure 3D] 3B illustrates a schematic diagram of a coil of the embolic system of FIG. 3A being delivered at a second time point, according to an embodiment of the present disclosure. [Figure 3E] 3B illustrates a schematic diagram of a coil of the embolic system of FIG. 3A being deployed at a third point in time, according to an embodiment of the present disclosure. [Figure 4] 1A and 1B illustrate schematic diagrams of an embolic coil having a hydrophobic coating being deployed, according to one embodiment of the present disclosure. [Diagram 5] 1A and 1B illustrate schematic diagrams of an embolic coil having a hydrophobic coating being deployed, according to one embodiment of the present disclosure. [Figure 6] 1A and 1B illustrate schematic diagrams of an embolic coil having a hydrophilic coating being deployed, according to one embodiment of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] The present disclosure is not limited to the specific embodiments described. The terms used herein are intended only to describe specific embodiments and are not intended to limit the scope of the appended claims. Unless otherwise defined, all technical terms used herein have the same meaning as commonly understood by those skilled in the art to which the present disclosure belongs.
[0012] Although embodiments of the present disclosure may be described with specific reference to medical devices and systems (e.g., embolization devices and / or accessory tools within the vasculature, etc.), it should be understood that such medical devices and systems may be used in a variety of medical procedures for occlusion, fixation, scaffolding, etc. Medical devices herein may include various medical devices for navigating a patient's anatomy, including, for example, catheters, microcatheters, visualization devices (e.g., fluoroscopy, ultrasound, x-ray, endoscopes, etc.), which may be inserted via different access points and approaches, for example, percutaneously, endoscopically, laparoscopically, or combinations thereof.
[0013] As used herein, the term "coil" is intended to include occlusion devices for embolization and the like. Such occlusion devices may be intended for aneurysms, blood vessels, tumors, other vasculature, or other body lumens.
[0014] As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms unless the context clearly indicates otherwise. The terms "comprises" and / or "comprising" or "includes" and / or "including" as used herein specify the presence of stated features, regions, steps, elements and / or components but do not exclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components and / or groups thereof.
[0015] As used herein, "proximal end" refers to the end of a device that is located along the device closest to a medical professional when the device is introduced into a patient, and "distal end" refers to the end of a device or object that is located along the device furthest from a medical professional when implanting, positioning, or delivering.
[0016] As used herein, the conjunction "and" includes each of the structures, components, features, etc. so connected, unless the context clearly dictates otherwise, and the conjunction "or" includes one or the other of the structures, components, features, etc. so connected, alone as well as in any combination and number, unless the context clearly dictates otherwise.
[0017] All numerical values are assumed to be modified by the term "about" in this specification, whether or not expressly indicated. The term "about", in the context of numerical values, generally refers to a range of numbers that one of ordinary skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many cases, the term "about" can include numbers that are rounded to the nearest significant figure. Other uses of the term "about" (i.e., in non-numerical contexts) can be assumed to have their ordinary and customary definition(s) as understood from and consistent with the context of this specification, unless otherwise specified. Recitation of numerical ranges by endpoints includes all numbers within that range, including the endpoints (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
[0018] It should be noted that references herein to "one embodiment," "some embodiments," "other embodiments," and the like, indicate that the described embodiment(s) may include a particular feature, structure, or characteristic, but that not all embodiments necessarily include that particular feature, structure, or characteristic. Moreover, such phrases do not necessarily refer to the same embodiment. Moreover, if a particular feature, structure, or characteristic is described in relation to an embodiment, it will be within the knowledge of one of ordinary skill in the art to affect such feature, structure, or characteristic in relation to other embodiments, unless expressly stated otherwise, whether or not explicitly described. That is, it is contemplated that various individual elements described below, even if not explicitly shown in a particular combination, can be combined or arranged with one another to form other additional embodiments or to complement and / or enhance the described embodiment(s), as will be understood by one of ordinary skill in the art.
[0019] 1, a coil 100 according to one embodiment of the embolization system of the present disclosure is shown deployed within an aneurysm 120. The illustrated system includes a microcatheter 110 extended within a blood vessel 122, with a distal end 110d of the microcatheter 110 directed toward the aneurysm 120 for treatment. The distal end 110d of the microcatheter 110 may be manipulated under observation, for example, by visualizing a radiopaque band 112 via fluoroscopy, among other possible techniques. The coil 100 is deployed distally from the microcatheter 110 to generally fill the volume of the aneurysm 120.
[0020] In various embodiments described herein, the coil may desirably be flexible for deployment and for filling the aneurysm. However, such flexible coils may have complications during delivery through a microcatheter. For example, the coil may prolapse, buckle, or crush due to a proximal member pushing the coil axially distally through the microcatheter. These complications may be addressed by providing the coil with a coating described herein that has a greater axial stiffness than the coil. The coating may aid in the pushability of the coil through the microcatheter and reduce these complications. However, such stiffness may be undesirable during deployment of the coil, for example, into an aneurysm. Thus, it is desirable for the coil to substantially lose the coating upon deployment after the coil is delivered through the microcatheter.
[0021] In various embodiments described herein, the coil may include a coating disposed around the exterior of the coil, around the entire surface of the coil, and / or within and throughout the coil. The coating may include a material that temporarily alters the properties of the coil, for example, for preparation, delivery, and / or deployment, which may have therapeutic properties, such as drug delivery, or may assist, inhibit, or accelerate bodily functions, such as clot formation. The coating may reduce friction of the coil during delivery, for example, by including lubricity, or by reducing surface area, such as by encapsulating and / or repositioning fibers extending from the coil. Such coatings may remain on the coil for extended periods of time. Alternatively, such coatings may be biodegradable, frangible, or soluble, such that they are removed from the coil during or shortly thereafter (e.g., prior to removal of the microcatheter that delivers or deploys the coil).
[0022] 2A, a coating is formed on the coil 200 according to an embodiment of the disclosed method. The coil 200 is immersed in a fluid 220 contained within a container 222. The fluid 220 includes a material or materials described herein that are intended to coat the coil 200. The coil 200 may be immersed in the fluid 220 at an even pace such that the fluid 220 contacts or adheres to substantially all of the outer surface of the coil 200 before the coil 200 contacts the bottom 222b of the container 222 and / or before the coil 200 contacts itself. The coil 200 may be immersed in the container 222 such that a portion of the coil 200 minimally contacts the side 222s of the container 222, which may help maximize contact between the fluid 220 and the surface of the coil 200. The entire length of coil 200 may be immersed in fluid 220 such that substantially all surfaces or all exposed or exterior surfaces of coil 200 are in contact with fluid 220. The length of coil 200 may be immersed for a period of time such that fluid 220 coats, adheres to, and / or bonds to coil 200.
[0023] 2B, a coating is shown formed on the coil 200 of FIG. 2A, and the coated coil 200 is removed from the vessel 222. The coil 200 is fully immersed in the fluid 220 (i.e., via the process of FIG. 2A) such that the surface of the coil 200 is in proper contact with the fluid 220. The coil 200 can be removed from the fluid 220 by gripping the ends of the coil 200 with a clamp 234 and lifting the coil 200 out of the fluid 220 in the vessel 222. The clamp 234 is coupled to an arm 230 of a gantry system that can translate the arm 230 vertically along a track 232. The clamp 234 can be positioned vertically above the vessel 222 such that further contact between the coil 200 and the vessel 222 is substantially avoided as the coil 200 rises out of the vessel 222. As the coil 200 rises out of the fluid 220, a portion 200p of the coil 200 is exposed to the atmosphere and aligns longitudinally along its length above the vessel 222. This longitudinal alignment forms a substantially straight coated coil 200 and may allow some of the fluid 220 to flow along the length of the coil 200 for coating and / or flow by gravity into the vessel 222 as the fluid 220 dries and / or adheres. The coil 200 may be removed from the fluid 220 and vessel 222 at a uniform pace (e.g., rising vertically along the length of the coil 200 at a speed of about 1 mm / s to about 25 mm / s, which may vary depending on the desired coating thickness, percentage solids of the fluid or coating, viscosity, etc.). The coil 200 may be completely removed from the fluid 220 and held by clamp 234 above the container 222 with the coil 200 substantially straightened along its longitudinal axis (e.g., with an end of the coil 200 positioned vertically above the opposite end of the coil 200 when fully raised) such that a coating is formed along the length of the coil 200.The coil 200 may be held by clamps 234 over the container 222 for a period of time to allow the coating to fully form (e.g., at room temperature for a period of time ranging from about 30 minutes to about 4 hours, e.g., to fully dry, cure, etc. (this may be accelerated by, e.g., increasing the temperature using, e.g., an in-line IR lamp, e.g., at about 60° C. to about 100° C., or by transferring the coil 200 to a convection oven, e.g., at about 40° C. to about 100° C., for about 15 minutes to about 1 hour)). Although an immersion coating (i.e., dip coating) process is shown, in various embodiments described herein, the coil may be coated by alternative methods such as solvent coating, spray coating, coating using a brush or other applicator, etc.
[0024] In various embodiments described herein, the coil may be formed from filaments into windings, for example, on a mandrel, along a longitudinal axis through and along the length of the coil. These filament windings may form the primary shape of the coil, for example, with the windings formed substantially linearly along the longitudinal axis. Adjacent windings may contact each other or may include gaps between them. Adjacent windings may be attached to each other, for example, via melt flow, adhesion, adhesives, coatings, etc. The primary shape may be formed into a secondary shape, for example, a spiral, a ball, a cone, a curvilinear shape, spaced apart or overlapping layered shapes, a serpentine, combinations thereof, etc. The secondary shape may be formed, for example, on a mandrel and heat set, such that, for example, the secondary shape causes the coil to deform to form the secondary shape, for example, when the coil is free-form and not under tension or constrained, for example, in a sheath, microcatheter, coating, etc. The coatings described herein may be formed on the filaments of the coil before forming the filaments, after forming the primary shape of the coil, or after forming the secondary shape of the coil. The coating may be continuous across the windings of the coil.
[0025] In various embodiments described herein, the filaments of the coil may comprise one or more materials, such as polymers including synthetic polymers, natural polymers, crosslinked polymers, non-crosslinked polymers, thermoset polymers, and / or thermoplastic polymers. Examples of polymers include polyolefins; polyurethanes; block copolymers (e.g., block copolymers having segments including esters, ethers, and / or carbonates); polyethers; polyimides; acrylates (e.g., cyanoacrylates); epoxy adhesive materials (e.g., one-part epoxy-amine materials, two-part epoxy-amine materials); polymers and / or copolymers of ethylene, propylene, butadiene, styrene, and / or thermoplastic olefin elastomers; polydimethylsiloxane-based polymers; rayon; cellulose; cellulose derivatives (e.g., nitrocellulose, cellulose esters ... Examples of suitable materials include natural rubber, polyesters (e.g., polyethylene terephthalate), polylactides, polyglycolides, polycaprolactones, copolymers of lactide, glycolide, and / or caprolactone, polyhydroxybutyrate, polyhydroxyvalerate, and copolymers of hydroxybutyrate and hydroxyvalerate, polyetheresters (e.g., polydioxanone), polyanhydrides such as polymers and copolymers of sebacic acid, hexadecanedioic acid, and other diacids, orthoesters, polyamino acids, polynucleic acids, polysaccharides, and polyhydroxyalkanoates. In various embodiments, the filaments can include mixtures and / or copolymers (e.g., block copolymers, random copolymers) of one or more of these materials. In various embodiments, the coil can include one or more fibers extending therefrom to promote clotting or occlusion, comprising one or more filament materials described herein.
[0026] In various embodiments described herein, the coating or the fluid forming the coating may include one or more materials, for example, one or more polymeric materials, such as those listed below. In some embodiments, the solid and / or brittle coating may be insoluble and may harden the coil for delivery, the coating may be brittle such that the coating may break into particles and peel off the coil upon deployment, and the particles may be soluble and biocompatible when absorbed or passed through the body. The coating may be formed from a substantially water-insoluble hydrophobic polymer, for example, having a number average molecular weight of about 1,000 g / mol to about 100,000 g / mol. The hydrophobic polymer may be biodegradable in the presence of blood, the polymer substantially degrading, for example, in a range of about one week to about one month. The coil may include a polymer, and the coating may include at least one of polylactic acid homopolymer, polyglycolic acid homopolymer, and copolymer of lactic acid and glycolic acid (PLGA), polycaprolactone, polyhydroxybutyric acid, polyhydroxyalkanoate, and aliphatic polyester. The coating may have a composition such that the coating fractures when the coil moves, bends, or deforms (e.g., at least a portion of the coil moves from its longitudinally aligned or primary shape) substantially outside its longitudinal axis and / or substantially outside the longitudinal axis of the microcatheter or sheath. For example, the coating may include one or more hydrophilic polymers. For example, the coating may include one or more of polyvinylpyrrolidone polymers or copolymers, polyethylene glycol, polyethylene oxide, polyvinyl alcohol, polyacrylic acid, copolymers of polyacrylamide, copolymers of hydroxypropyl methacrylamide, polyamines, xanthan gum, pectin, chitosan derivatives, sodium alginate, sodium carboxymethylcellulose, hydroxypropylcellulose, hyaluronic acid, dextran, carrageenan, guar gum, cellulose ethers, albumin, starch, starch-based derivatives, and the like.In some embodiments, the composition may include a hydrophilic polymer having a number average molecular weight in the range of about 10,000 g / mol to about 1,000,000 g / mol. In certain beneficial embodiments, the coating may be formed from a polyvinylpyrrolidone (PVP) polymer having a number average molecular weight in the range of about 10,000 g / mol to about 1,000,000 g / mol.
[0027] 3A, the preparation of one embodiment of an embolic system is shown, including a sheath 302 housing a coated embolic coil 300 that has been introduced into a working lumen of a microcatheter 310. The sheath 302 can protect the coil 300 during packaging, for example from trauma or abrasion, and can aid in preparing the coil 300 for delivery to a patient. The coated coil 300 is in a primary shape substantially aligned along its length with a longitudinal axis l that extends through the microcatheter 310. The distal end of the sheath 302 housing the coil 300 extends through an access hub 306 at the proximal end of the microcatheter 310. The outer diameter of the sheath 302 can substantially match the inner diameter of the microcatheter 310 such that the distal end of the sheath 302 is securely seated within the proximal end of the microcatheter 310. Alternatively, the outer diameters of both the sheath 302 and the microcatheter 310 can substantially match such that they abut one another. In the configuration shown in FIG. 3A, the coil 300 is freely slidable, for example, from within the delivery lumen of the sheath 302 into the microcatheter 310 substantially along the longitudinal axis l.
[0028] 3B, the sheath 302 of the embolization system of FIG. 3A is shown with a delivery filament 304 slidably extended within the proximal end of the sheath 302. The coil 300 may be delivered from within the sheath 302 into the microcatheter 310 of FIG. 3A by distal translation of the delivery filament 304 by a medical professional 350. Further translation of the delivery filament 304 into the sheath 302 will result in further delivery of the coil 300 into the microcatheter 310. The insertable length of the delivery filament 304 substantially matches the length of the delivery sheath 302 such that the distance L between the proximal end of the delivery filament 304 and the proximal end of the sheath 302 is substantially equal to the length of the coil 300 remaining within the sheath 302 (i.e., the remainder of the length of the coil 300 is within the microcatheter 310). When the proximal end of the delivery filament 304 approaches the proximal end of the sheath 302 (e.g., when L is about 10 cm, etc.), the user 350 may stop translating the delivery filament 304 into the sheath 302 and may withdraw the sheath 302 proximally along with the delivery filament 304 until the sheath 302 is retracted from the system. The user 350 may then further translate the delivery filament 304 through the hub 306 and into the microcatheter 310 to further deliver, release, and / or deploy the coil 300 without losing the delivery filament 304 within the sheath 302 if the sheath 302 is not retracted proximally.
[0029] 3C shows the coil 300 of the embolization system of FIGS. 3A and 3B being delivered and deployed within the aneurysm 320. The coil 300 includes a coating 308. The coated coil 300 has been translated distally through the microcatheter 310 by distal translation of the delivery filament 304 of FIG. 3B through the microcatheter 310 substantially along the longitudinal axis 1 of the microcatheter 310 and / or the proximal portion of the coil 300. As the distal end 300d of the coil 300 extends distally out of the microcatheter 310 past a distal marking band 312 that may be visualized, e.g., a radiopaque distal marking band 312 that may be visualized by fluoroscopy, the distal end 300d is free to move partially out of overall alignment (i.e., generally out of alignment) with the longitudinal axis 1 of the microcatheter 310 and / or the proximal portion of the coil 300. In various embodiments described herein, a portion of the coil may move out of general alignment with the longitudinal axis due to, for example, bodily fluid flow, gravity, contact with bodily fluids, contact with tissue, contact with a medical device, accidental, or a combination thereof. When the distal end 300d of the coil 300 and the coating 308 exit the microcatheter 310 and move out of general alignment with the longitudinal axis l, a portion 308d of the friable coating 308 may fracture into particles 300e and peel off from the coil 300, although similar or alternative coating transitions may occur as described herein, including with reference to Figures 4-6. When the coating 308 peels off the coil 300, the properties of the coil 300 may change as described herein. For example, the coating 308 can increase the stiffness of the coil 300 while it is on the coil 300 so that the coil 300 can be more easily pushed by the delivery filament 304 through the microcatheter 310, and as the coating 308 peels off from the distal end 300d of the coil 300, the coil 300 can become more flexible for deployment into the aneurysm 320.Additionally, as the coating 308 peels off the coil 300 and breaks into particles 308e, the materials of both the coating 308 and the coil 300 can be exposed to the body, e.g., pro-thrombotic agents, thrombogenic fibers, etc., as described herein.
[0030] 3D shows the coil 300 of the embolic system of FIGS. 3A-3C being further delivered and deployed within the aneurysm 320. The delivery filament 304 is translated distally through the microcatheter 310 until the distal end of the delivery filament 304 abuts the proximal end of the coil 300. As the coil 300 continues to be translated distally out of the microcatheter 310 and is substantially out of alignment with the longitudinal axis l, portions 308d of the coating 308 on the exterior of the microcatheter 310 continue to fracture and flake off into particles 308e such that the coil 300 is able to flex further during deployment within the aneurysm 320 due to the absence of the coating 308. Once the delivery filament 304 is a distance X away from the distal end of the marking band 312, the medical professional operating the system can visualize that the coil 300 is likely to be fully deployed from the microcatheter 310 (e.g., by employing a radiopaque delivery filament 304 that may be visualized by fluoroscopy) or can infer that the coil 300 is likely to be fully deployed from the microcatheter 310 based on the length of the delivery filament 304 that has been translated distally through the microcatheter 310. The distance X can be a variety of lengths, such as, for example, about one centimeter. Once the coil 300 is nearly fully deployed, the medical professional can reposition the coil 300, if necessary, by manipulating the microcatheter 310 and / or translating the delivery filament 304. In various embodiments described herein, the delivery filament 304 and the coil 300 can be temporarily coupled to one another during delivery, such that if repositioning is difficult, distal and proximal translation of the delivery filament 304 similarly translates the coil 300 to allow complete proximal withdrawal and discarding of the delivery filament 304 and the coil 300. For example, the delivery filament 304 can have a geometry that substantially interlocks with a complementary geometry of the coil, e.g., a channel, a C-link, etc.
[0031] FIG. 3E illustrates the coil 300 of the embolization system of FIGS. 3A-3D fully deployed within the aneurysm 320. Once a substantial portion of the coil 300 is confirmed to be in the desired deployment position of FIG. 3D, the delivery filament 304 may be translated distally past the marking band 312 at the distal end of the microcatheter 310 for full deployment of the coil 300 (i.e., release of the coil 300 from the microcatheter 310). The remaining portion 308d of the coating has been broken into particles 308e from the coil 300 such that the entire coil 300 is free of the coating and can flex to deploy into the aneurysm 320. If the delivery filament 304 is coupled to the coil 300, the delivery filament 304 may be manipulated, e.g., rotated, agitated, etc., such that the coil 300 is decoupled from the delivery filament 304 outside of the microcatheter 310. After deployment of coil 300, if desired, additional coils can be delivered and deployed through microcatheter 310 in a similar manner, for example to further fill aneurysm 320.
[0032] 4 and 5, in various embodiments described herein, the coating 408, 508 of the coil 400, 500 may transition in various ways as the coil 400, 500 is deployed. For example, referring to FIG. 4, the coating 408 including a hydrophobic material may be substantially rigid during delivery within the microcatheter 410 (and / or sheath or other elongate member, not shown), allowing the coil 400 to be advanced distally without prolapse. As the coating 408 (i.e., a brittle coating) is extended distally from the microcatheter 410, a portion 408d of the coating 408 may not substantially conform to the microcatheter 410 and / or the proximal remaining portion of the coating 408 may fracture into particles 408e and peel away from the coil 400, allowing the coil 400 to bend (e.g., for deployment) without the coating 408. Because the coating 408 is not substantially adhered to the coil 400, the particles 408e fracture off of the coil 400. Alternatively, referring to FIG. 5, the coating 508 may be substantially adhered to the coil 500 such that a portion 508d of the coating 508 extends distally from the microcatheter 510 and is not aligned with the proximal remainder of the microcatheter 510 and / or coating 508, causing the portion 508d to crack along the coil 500 into at least a partially separated portion 508e (i.e., the brittle coating portion 508d cracks, thereby becoming less stiff than it was prior to cracking), allowing the coil 500 to bend with the cracked coating 508e. The portion 508d of the coating cracks, but remains substantially along the coil 500 because the coating 508 is substantially adhered to the coil 500. Such hydrophobic coatings 408, 508 may be more rigid (e.g., glass-like) in a substantially dry state and may not be rapidly plasticized by fluids. Such hydrophobic coatings 408, 508 may crack during deployment of the coil 400, 500, or the coating 408, 508 may remain substantially along the deployed coil 400, 500 if there is substantial adhesion between the coating 408, 508 and the coil 400, 500.If the coating 408, 508 is not substantially adherent to the coil 400, 500, the coating 408, 508 may substantially crumble away from the deployed coil 400, 500 during or after deployment and may biodegrade, pass through or be metabolized by the body.
[0033] 6, in various embodiments described herein, the coating 608 of the coil 600 may dissolve as the coil 600 is deployed. The coating 608 along the coil 600 includes a hydrophilic material that may be substantially rigid during delivery within the microcatheter 610 (and / or sheath or other elongate member, not shown), allowing the coil 600 to be advanced distally through the microcatheter 610 without prolapse. As the coating 608 is extended distally from the microcatheter 610, a portion 608d of the coating 608 is substantially exposed to and / or saturated within an aqueous fluid (e.g., blood). A portion 608d of the coating 608 disperses into particles 608e and / or solution and peels away from the coil 600, allowing the coil 600 to bend as it is deployed in the absence of the coating 608. Such a hydrophilic coating 608 may be substantially more rigid (e.g., glass-like) in a dry state and may be rapidly plasticized by the fluid, reducing its stiffness. The duration for coating 608 to plasticize in fluid to a desired flexibility may depend on the composition of coating 608. In some embodiments, coating 608 may peel off from the coil during and / or after deployment of coil 600.
[0034] All of the devices and / or methods disclosed and claimed herein may be made and executed without undue experimentation in light of the present disclosure. While the devices and methods of the present disclosure have been described with reference to preferred embodiments, it may be apparent to those skilled in the art that modifications may be made to the devices and / or methods, and to the steps or sequence of steps of the methods described herein, without departing from the concept, spirit and scope of the present disclosure. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the present disclosure as defined by the appended claims.
Claims
1. 1. An embolization system comprising: The embolization system includes a microcatheter having a proximal end, a distal end, a longitudinal axis, and a working lumen therethrough; the embolization system comprises a sheath having a proximal end, a distal end, and a delivery lumen therethrough, the distal end of the sheath configured to be insertable into the working lumen at the proximal end of the microcatheter; the embolization system comprises a coil having a proximal end, a distal end, and a length between the proximal end and the distal end, the coil being slidably disposed within the sheath; the embolization system comprises a coating disposed about the coil; the embolization system comprises a delivery filament configured to be slidably disposed within the sheath proximal to the coil to release the coil from the distal end of the sheath into the working lumen of the microcatheter, and configured to be slidably disposed within the working lumen of the microcatheter proximal to the coil to release the coil from the working lumen at the distal end of the microcatheter to a target site; the coil has a primary shape conforming to the microcatheter when disposed within the microcatheter and a secondary shape conforming to a curved line when released from the microcatheter to the target site; the coating is configured to spall off the coil when the coil transitions from the primary shape to the secondary shape. Embolization system.
2. The embolic system of claim 1 , wherein the coating is formed from a hydrophilic polymer having a number average molecular weight of about 10,000 g / mol to about 1,000,000 g / mol.
3. The embolization system of claim 1 or 2, wherein the coating is disposed about an outer surface of the coil.
4. The embolic system of any one of claims 1 to 3, wherein the coil comprises a polymer and the coating comprises a hydrophilic polymer.
5. The embolic system of any one of claims 1 to 4, wherein the coil further comprises a prothrombotic factor covered by the coating.
6. The embolic system of any one of claims 1 to 5, wherein the delivery filament comprises a distal end reversibly coupled to the proximal end of the coil.
7. The embolic system of any one of claims 1 to 6, further comprising at least one fiber coupled to the coil and disposed within the coating.
8. An embolic coil comprising: The embolic coil comprises a coil filament disposed in adjacent windings about a longitudinal axis; the embolic coil comprises a coating disposed about said windings; the coil filament has a primary shape that is linear and a secondary shape that is curved linear; the coating is configured to spall off the coil filament when the coil filament transitions from the primary shape to the secondary shape. Embolization coils.
9. The embolic coil of claim 8 , wherein the coating comprises a hydrophilic polymer.
10. 10. The embolic coil of claim 8 or 9, wherein the coating is insoluble in blood while it remains intact and disposed about the windings, and the coating is soluble in blood when fractured.
11. The embolic coil of any one of claims 8 to 10, wherein the coating has a lower coefficient of friction than the coil filaments.
Citation Information
Patent Citations
Coupling and uncoupling device, and its assembly method and usage method
JP2009513274A
microfabricated embolization device
JP2016508850A
Occluding device for occlusion of a body vessel and method for making the same
US20100004672A1
Medical instrument with hydrophilic member and hydrophobic member laminated
WO2018181179A1
